Published in Zahnarztl Mitt on April 16, 1974
Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet (2003) 1.92
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther (2000) 1.61
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther (2000) 1.27
Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res (2001) 1.11
N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex. Int J Clin Pharmacol Ther Toxicol (1990) 1.02
Genetic influences on baroreflex function in normal twins. Hypertension (2001) 1.01
Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab (2001) 1.00
Osmosensitive mechanisms contribute to the water drinking-induced pressor response in humans. Neurology (2005) 0.98
Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol (1993) 0.91
Disposition kinetics of metronidazole in children. Eur J Clin Pharmacol (1983) 0.86
Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int J Clin Pharmacol Ther (1995) 0.85
Improved detection of bacterial central nervous system infections by use of a broad-range PCR assay. J Clin Microbiol (2014) 0.84
Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test. Skin Pharmacol Physiol (2008) 0.84
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing. Eur J Clin Microbiol Infect Dis (2008) 0.83
Limited effect of systemic beta-blockade on sympathetic outflow. Hypertension (2001) 0.83
Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo. J Interferon Res (1989) 0.82
Anticholinergic properties of propiverine and its metabolites. Pharmazie (1990) 0.80
Pharmacokinetics of Metronidazole in pregnant women. Chemotherapy (1981) 0.80
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twins. Clin Pharmacol Ther (2009) 0.78
Oxidation phenotyping with debrisoquine in Germany (East). Pharmazie (1990) 0.77
Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine. Eur J Drug Metab Pharmacokinet (1994) 0.77
[Differential value of various vital stains of corneal endothelium]. Ophthalmologe (1995) 0.77
N-acetylator phenotypes in hyperthyroidism. Int J Clin Pharmacol Ther Toxicol (1988) 0.77
Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes. J Interferon Res (1991) 0.77
N-Acetylation phenotyping with sulfamethazine--problems of sampling. Pharmazie (1989) 0.77
Tyramine in the assessment of regional adrenergic function. Biochem Pharmacol (2006) 0.77
The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects. Horm Metab Res (2006) 0.76
Kidney transplantation improves quality of life. Transplant Proc (1997) 0.76
Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics. Pharmazie (1985) 0.76
N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome. Br J Clin Pharmacol (1991) 0.75
Pharmacokinetic interactions between isoniazid and theophylline in rats. J Pharm Pharmacol (1992) 0.75
Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: in vivo microdialysis study. Acta Neurol Scand (2004) 0.75
[Recommendations for dental radiography methods]. Int Dent J (1978) 0.75
[Pharmacokinetics of dihydralazine following intravenous administration in laboratory animals]. Pharmazie (1987) 0.75
[Serum hyposomolarity, brain edema and the bulbar brain syndrome as complications in the course of severe cranio-cerebral injuries in children]. Anaesthesiol Reanim (1991) 0.75
Circadian-time rhythm of hepatic protein kinase C of rats pretreated with phenobarbital. Pharmazie (1995) 0.75
Comparative bioavailability of metronidazole formulations (Vagimid) after oral and vaginal administration. Int J Clin Pharmacol Ther (1995) 0.75
Trichloroethylene vapours do not produce dominant lethal mutations in male mice. Arch Toxicol (1980) 0.75
[Effect of thyroid hormones on noradrenaline-stimulated lipolysis in obesity]. Z Gesamte Inn Med (1984) 0.75
[Symposium on caries prophylaxis by fluorides held on the 29th and 30th of April 1969 in the Federal Ministry of Health]. Zahnarztl Mitt (1969) 0.75
[Dental manpower in the German Federal Republic]. Dent Echo (Heidelb) (1973) 0.75
Circadian time-dependent kinetics of theophylline and its modulation by phenobarbital pretreatment in rats. Chronobiol Int (1993) 0.75
The estimation of drug plasma levels in epileptics. Int J Clin Pharmacol Biopharm (1978) 0.75
[Electronic data processing as an aid in occupational medicine documentation - methods, experiences, perspectives]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1982) 0.75
A bioequivalence study on retarded formulations of carbamazepine tablets. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
[Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease]. Ther Ggw (1972) 0.75
Pharmacokinetics of almitrine in healthy volunteers and patients with essential hypertension. Biomed Biochim Acta (1991) 0.75
[Density of dentists in the Federal Republic of Germany]. Zahnarztl Mitt (1973) 0.75
[Phenytoin kinetics in toxic serum levels]. Psychiatr Neurol Med Psychol (Leipz) (1983) 0.75
[Scleritis nodulosa necroticans treated by extra-corneal corneal graft]. Ophthalmologica (1969) 0.75
[The binding of propranolol, dihydralazine and selected metabolites to adsorbent resins for hemoperfusion]. Pharmazie (1986) 0.75
Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats. Pharmazie (1992) 0.75
[The behavior of the thyrotropin-releasing hormone test in fasting with and without triiodothyronine administration]. Z Gesamte Inn Med (1982) 0.75
[Fear of AIDS: a new disease? Increasing number of AIDS phobics-- beginning of diagnosis and treatment]. Fortschr Med (1988) 0.75
[Capacity calculations for the rising generation of dentists]. Zahnarztl Mitt (1971) 0.75
Pharmacokinetic interactions between nocloprost, acetylsalicylic acid and ethanol. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Effects of streptolysin O, picibanil (OK 432) and interferon alpha 2A on cytochrome P-450-dependent monooxygenases and arylamine N-acetyltransferase in rat liver. Immunopharmacol Immunotoxicol (1995) 0.75
Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T. Int J Clin Pharmacol Biopharm (1978) 0.75
[Enlargement of the sella in primary hypothyroidism]. Z Gesamte Inn Med (1981) 0.75
[Prognosis, chronification and therapeutic relations in unsatisfactorily improved secondary faulty developments with cardiovascular affections]. Psychiatr Neurol Med Psychol (Leipz) (1979) 0.75
[Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)]. Zentralbl Bakteriol Orig A (1979) 0.75
[The pharmacokinetics of 2-methyl-4-nitroimidazole-1-ethanol (isometronidazole) in man]. Pharmazie (1988) 0.75
[Caffeine-stimulated lipolysis in relation to pathologic pregnancy]. Zentralbl Gynakol (1976) 0.75
Debrisoquine and N-acetylation polymorphism in Syria. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
Studies on the kinetics and distribution of dihydralazine in pregnancy. Biol Res Pregnancy Perinatol (1986) 0.75
[Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)]. Z Gastroenterol (1993) 0.75
[Orciprenaline in haemorrhagic shock (author's transl)]. Anaesthesist (1973) 0.75
The influence of the acetylator phenotype for the clinical use of dihydralazine. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
[Recommendations for the handling of mercury]. Int Dent J (1978) 0.75
[Dental manpower in the German Federal Republic]. Dent Labor (Munch) (1973) 0.75
[Ophthalmological and histopathological findings in maple syrup disease]. Fortschr Ophthalmol (1983) 0.75
Interactions of dihydralazine with furosemide in hypertonic patients. Int J Clin Pharmacol Ther Toxicol (1987) 0.75
[The emphasis was on prevention. European seminar on dental health services in Göteborg]. Zahnarztl Mitt (1972) 0.75
[Quantitative determination and kinetics of dihydralazine in hypertension patients]. Pharmazie (1985) 0.75
[Pharmacokinetic interactions between dihydralazine and INH in rabbits]. Pharmazie (1988) 0.75
[Duration of fluorescein diacetate in corneal endothelium]. Ophthalmologe (1993) 0.75
[Introduction of a model in industrial medicine--data utilization in occupational medicine]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1980) 0.75
Potential pharmacokinetic interactions of nocloprost clathrate with retarded theophylline and enteric coated diclofenac after single and repeated premedication in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
[Symposium on caries prophylaxis by fluorides]. Zahnarztl Mitt (1969) 0.75
[The wave of graduates is rolling]. Zahnarztl Mitt (1974) 0.75
Vital staining by fluorescein diacetate (FDA). A method for the estimation of corneal endothelium. Acta Ophthalmol (Copenh) (1990) 0.75
[Basic requirements for controlled clinical studies of periodontal diseases]. Int Dent J (1978) 0.75
[Various practical comments on microorbital complications]. Cesk Stomatol (1979) 0.75
Tryptophan metabolic studies in patients with presenile cataracts. Biomed Biochim Acta (1990) 0.75
Kinetics of antipyrine and sulfamethazine in patients recovered from dihydralazine-hepatitis. Int J Clin Pharmacol Ther Toxicol (1989) 0.75
[The acetylator phenotype in patients with urinary bladder cancer]. Z Urol Nephrol (1989) 0.75
Debrisoquine 4-hydroxylation and sulphamethazine N-acetylation in patients with schizophrenia and major depression. Br J Clin Pharmacol (1996) 0.75
Effects of nocloprost on some monooxygenases of rat and human liver. Arzneimittelforschung (1993) 0.75
Bioavailability of metronidazole vaginal tablets (Vagimid). Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Effects of nocloprost clathrate on absorption of acetylsalicylic acid. Int J Clin Pharmacol Ther (1994) 0.75
[Symposium on caries prevention with fluorides. 2]. Zahnarztl Mitt (1969) 0.75
[Study of the pharmacokinetics of morphocycline, tetraverine and oxytetracycline]. Farmakol Toksikol (1978) 0.75
Sublytic doses of streptolysin O-effects on the metabolic fate of procainamide in rats. Pharmazie (1991) 0.75
Bioavailability of metronidazole formulations (Vagimid). Pharmazie (1992) 0.75
[Semblance of victory in Lübeck. Symposium on drinking water fluoridation]. Zahnarztl Mitt (1969) 0.75
[Classification of epidemiological studies of dental caries and definitions of related terms]. Int Dent J (1976) 0.75
[Recommendations of the Science Advisory Board of 11 May 1973]. Zahnarztl Mitt (1973) 0.75
Drug oxidation and N-acetylation in rats pretreated with subtoxic doses of streptolysin O. Biochem Pharmacol (1991) 0.75